First administration of PB004 to animals

On June 7th, 2022, Pure Biologics commenced its first pilot preclinical study in the PB004 project developing a potential drug for the treatment of solid tumors and leukemia.

News

Inquiries

13 November

2020

Antibody E-Conference 2020

On Friday, November 13, 2020 at 13:00 the Antibody E-conference 2020 took place.

Pure Biologics movie – immunotherapeutic portfolio

12 November

2020

Pure Biologics movie – immunotherapeutic portfolio

Watch a video about the most advanced projects targeting colon cancer, non-small cell lung cancer and triple-negative breast cancer.

Antibody E-Conference 13.10.2020 – invitation

10 November

2020

Antibody E-Conference 13.10.2020 – invitation

Pure Biologics antibody e-conference on November 13, 2020, 13:00!

Project PB001 – partner for preclinical research

5 November

2020

Project PB001 – partner for preclinical research

We chose a partner to carry out the first panel of preclinical studies in the PB001 project.

5 November

2020

Pure Biologics – new webpage!

9 October

2020

Zapytanie Ofertowe – PB/MAGBBRIS/0/5/20 09.10.2020

17 June

2020

Zapytanie Ofertowe – PB/MAGBBRIS/0/4/20 17.06.2020

10 April

2020

Zapytanie Ofertowe – PB/MAGBBRIS/0/3/20 10.04.2020

25 January

2020

Zapytanie Ofertowe – PB/MAGBBRIS/0/2/20 25.01.2020

21 January

2020